29 September 2017 - But only if the Trump administration lets it refuse to cover some medicines.
Massachusetts' Medicaid program MassHealth earlier this month asked the federal government for permission to refuse to pay for some drugs, potentially reducing its costs and improving its negotiating position with drugmakers.
This is just one Medicaid program in one state. But other states could follow suit. And this suggests the pharma industry shouldn't assume its drug-pricing worries are over.